HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IFF CEO

This article was originally published in The Rose Sheet

Executive Summary

Robert Amen named Chairman and CEO of the board, tasked with leading the company through its next phase of growth, International Flavors & Fragrances announces June 29. The appointment is effective July 1. "Having conducted a thorough search, we feel strongly that Rob is the right person to lead IFF," the company says, noting Amen is a "seasoned exec with a proven ability to strategically manage and grow businesses around the globe." Amen most recently served as president of International Paper Company. He succeeds Arthur Martinez, who has served as interim chairman and CEO following the retirement of former head Richard Goldstein in May (1"The Rose Sheet" May 15, 2006, In Brief)...

You may also be interested in...



IFF management

International Flavors & Fragrances Chairman and CEO Richard Goldstein retired May 9 following the firm's annual shareholder meeting, IFF reports. Goldstein, who became CEO in 2000, announced in January he would step down this month (1"The Rose Sheet" Jan. 23, 2006, In Brief). Executive search firm Spencer Stuart was retained to assist IFF in hiring Goldstein's successor. "That process is continuing and is progressing well," according to the firm. IFF Lead Director Arthur Martinez is appointed chairman and CEO on an interim basis during shareholder meeting...

JT Gains World-First Topical JAK Inhibitor Approval

Latest new drug approvals in Japan include the first anywhere for a topical JAK inhibitor and also a marketing clearance for a new contender in the large prostate cancer space.

QUOTED. 27 January 2020. John McKay.

Consultant John McKay encourages device makers to ask questions of the US FDA’s inspection team during a facility audit. Check out his advice here.

UsernamePublicRestriction

Register

RS014045

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel